Lenalidomide for Adult Histiocyte Disorders

NCT02523040 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Langerhans Cell Histiocytosis (LCH)
Histiocytoses Erdheim-chester Disease
Histiocytic Sarcoma (HS)

Interventions

DRUG: Lenalidomide

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]